S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CatalentSarepta TherapeuticsOno PharmaceuticalIonis PharmaceuticalsJazz Pharmaceuticals
SymbolNYSE:CTLTNASDAQ:SRPTOTCMKTS:OPHLFNASDAQ:IONSNASDAQ:JAZZ
Price Information
Current Price$58.74$123.88$18.38$60.66$133.80
52 Week RangeBuyBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$64.00$201.20N/A$75.82$168.31
% Upside from Price Target8.95% upside62.42% upsideN/A24.99% upside25.79% upside
Trade Information
Market Cap$8.56 billion$9.18 billion$9.45 billion$8.53 billion$7.67 billion
Beta1.72.20.992.021.18
Average Volume1,283,724648,53015695,810406,811
Sales & Book Value
Annual Revenue$2.52 billion$301.03 million$2.60 billion$599.67 million$1.89 billion
Price / Sales3.4230.673.6314.234.00
Cashflow$3.20 per shareN/A$1.03 per share$3.14 per share$16.28 per share
Price / Cash18.34N/A17.7919.298.22
Book Value$11.72 per share$15.45 per share$9.20 per share$8.63 per share$45.71 per share
Price / Book5.018.022.007.032.93
Profitability
Net Income$137.40 million$-361,920,000.00$464.98 million$273.74 million$447.10 million
EPS$1.62($5.46)$0.90$2.96$12.24
Trailing P/E Ratio69.93N/A20.2020.2212.80
Forward P/E Ratio29.52N/A15.44288.868.35
P/E Growth$2.63N/AN/A$34.35$0.73
Net Margins5.44%-169.87%N/A52.26%29.61%
Return on Equity (ROE)15.21%-55.44%N/A36.31%27.99%
Return on Assets (ROA)4.41%-35.16%N/A17.81%15.01%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.65%0.49%N/A0.44%0.56%
Current Ratio1.98%6.31%N/A10.39%3.89%
Quick Ratio1.60%5.54%N/A10.31%3.71%
Ownership Information
Institutional Ownership PercentageN/A97.13%N/A86.49%88.60%
Insider Ownership Percentage1.30%6.60%N/A2.40%4.30%
Miscellaneous
Employees12,3004993,4807371,360
Shares Outstanding146.42 million74.54 million514.12 million140.66 million56.57 million
Next Earnings Date5/5/2020 (Estimated)2/26/2020 (Confirmed)2/21/2020 (Estimated)2/26/2020 (Confirmed)2/25/2020 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel